The findings, which were part of a larger review commissioned by the World Health Organisation, suggested there was "no ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

A mini-review in Brain Medicine examines the distinct and often opposing roles of AMPKα1 and AMPKα2 isoforms in Alzheimer's ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing ...

AI powered analysis of routine EEG scans is now distinguishing Alzheimer’s disease from frontotemporal dementia while also ...

Alzheimer’s disease is relentless. It gradually affects memory, independence, and the ability to manage everyday activities.

And while Samsung's smartwatches are really good at monitoring cardiovascular and even metabolic health, one area they ...

The county’s Health and Social Care Partnership (HSCP) has developed the strategy after a year long survey of patients and ...

A watch that can potentially identify early signs of dementia, a toothbrush that can smell diabetes and a robot that can fold ...

Groundbreaking research reveals that long-term use of common drugs for depression, bladder control, and Parkinson’s could be ...

New AI-enabled research tool, Cardiovascular Knowledge Graph (CardioKG), connects heart scans with genetics, boosting drug ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...